NCT01971489 2023-04-27Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsRoswell Park Cancer InstitutePhase 1 Withdrawn
NCT01501604 2015-09-17BKM120 in Cancers With PIK3CA Activating MutationsMassachusetts General HospitalPhase 2 Withdrawn